IPO Trending
MANKINDEQ / NSE, BSEListed

Mankind Pharma Limited

Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across a wide range of acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. The company offers over 36 brands such as Manforce, Moxikind-CV, Amlokind-AT, Prega News, and Gudcef, supported by one of the largest distribution networks of medical representatives in India, with over 80% of doctors prescribing its formulations. Ranked 4th in domestic sales in FY2022, Mankind Pharma has received numerous awards, including The Best of Bharat Awards 2022, National Awards for Manufacturing Competitiveness Silver Medal 2021, and recognition for Best Design in Healthcare and performance management excellence.

₹1,026 - ₹1,08015.32x sub
Listed Price1300.00
Listing Gain+20.37%
Subscription15.32x total demandUpdated 20 May 2026, 10:15 AM
QIB51.74x
🔥 Blockbuster Sizzling Demand!Offered: 76,11,181 sh
Nib4.00x
Popular / Warm DemandOffered: 57,08,386 sh
Hnis(10l +)5.26x
Popular / Warm DemandOffered: 38,05,591 sh
Hnis (2-10l)1.48x
Fully Subscribed (Safe)Offered: 19,02,795 sh
Retail0.97x
Steady / DevelopingOffered: 1,33,19,566 sh
CategoryOfferedAppliedTimes
QIB76,11,18139,38,34,10351.74x
Nib57,08,3862,28,22,7614x
Hnis(10l +)38,05,5912,00,00,5005.26x
Hnis (2-10l)19,02,79528,22,2611.48x
Retail1,33,19,5661,28,56,0380.97x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB42,534.08822.0151.74x
Retail1,388.451,438.510.97x
Hnis 2+304.8205.51.48x
Hnis 10+2,160.054115.26x
Mankind Pharma Limited IPO Subscription | GMP, Allotment & Financials | IPO Trending